Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
82.2M
-
Shares change
-
+1.67M
-
Total reported value, excl. options
-
$1.91B
-
Value change
-
+$45.6M
-
Put/Call ratio
-
0
-
Number of buys
-
80
-
Number of sells
-
-100
-
Price
-
$23.23
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2023
217 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q1 2023.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.2M shares
of 93.1M outstanding shares and own 88.31% of the company stock.
Largest 10 shareholders include BlackRock Inc. (14.1M shares), VANGUARD GROUP INC (9.3M shares), Camber Capital Management LP (7M shares), WELLINGTON MANAGEMENT GROUP LLP (6.73M shares), STATE STREET CORP (4.6M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (4.2M shares), BANK OF AMERICA CORP /DE/ (3.43M shares), EARNEST PARTNERS LLC (3.06M shares), DIMENSIONAL FUND ADVISORS LP (2.72M shares), and Artisan Partners Limited Partnership (2.21M shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.